Bioequivalence and Drug - Drug Interaction Study of Metformin/Gliclazide in Healthy Participants
Clinical trial NCT03467945 · COMPLETED
Trial details
- NCT number
- NCT03467945
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-16
- Primary completion
- 2018-04-29
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.